For US HealthCare Professionals
When it’s time for a generic treatment for relapsing-forms of MS—go Glatopa. Glatopa is the first FDA-approved substitutable generic glatiramer acetate, and it's made in the USA. Patients taking Glatopa are backed by GlatopaCare, which provides free, ongoing individualized support—whether they’re new to glatiramer acetate or making a switch. And it’s all provided by Sandoz, a Novartis Division, known for high-quality generics.1,3,4
ENCOURAGE YOUR PATIENTS TO ENROLL IN GLATOPACARE TODAY
Glatopa Co-Pay Program Eligibility
The Glatopa Co-Pay Program provides up to $9,000 in annual Co-Pay support for Glatopa prescriptions. This program is not health insurance. This program is for insured patients only; uninsured cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TriCare, or private indemnity, or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. Card may not be combined with any other rebate, coupon, or offer. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.